Abbott

$107.47
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.21 (+1.14%) Today
-$0.15 (-0.14%) As of 10:00 PM UTC after-hours

Why Robinhood?

You can buy or sell Abbott and other stocks, options, and ETFs commission-free!

About ABT

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL. The listed name for ABT is Abbott Laboratories.

CEO
Robert B. Ford
Employees
107,000
Headquarters
Abbott Park, Illinois
Founded
1888
Market Cap
190.74B
Price-Earnings Ratio
57.06
Dividend Yield
1.34
Average Volume
4.37M
High Today
$107.75
Low Today
$105.87
Open Price
$106.52
Volume
1.98M
52 Week High
$115.14
52 Week Low
$61.61

Collections

ABT Earnings

$0.00
$0.33
$0.65
$0.98
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Jan 20, Pre-Market

You May Also Like